Vertex Pharmaceuticals Incorporated Company Profile Report 2018
Vertex Pharmaceuticals Incorporated

Business Overview:

Vertex Pharmaceuticals Incorporated (VPI) is focused on developing and commercializing therapies for the treatment of cystic fibrosis, or CF, and advancing its research and development programs in other diseases. Company’s key products include ORKAMBI (lumacaftor in combination with ivacaftor), KALYDECO (ivacaftor) and SYMDEKO (tezacaftor in combination with ivacaftor).

Table of Contents:
  • Company Overview
  • Business Description
  • Products and Services
  • Geo Presence
  • Financial Performance
  • Growth Strategy
  • Key Competitors
  • Board of Directors
  • Senior Leadership Team
  • Key Management Bios
  • History

This is a single user license,allowing one specific user access to the product.

*Electronic PDF/PPT copy delivered via email.